Document Detail

Oncogenically activated or ligand-stimulated neu kinase stimulates neurite outgrowth in PC12 cells.
MedLine Citation:
PMID:  7915994     Owner:  NLM     Status:  MEDLINE    
Retroviral vectors pDOL/NeuN and pDOL/NeuT were used to express normal and transforming rat neu cDNAs in PC12 cells. DOL/NeuT-infected cells exhibited a high frequency of spontaneous neurite outgrowth while DOL/NeuN-infected cells showed neurite outgrowth in the presence of heregulin, a putative ligand for the neu receptor tyrosine kinase. In both cases, neurite outgrowth was preceded by phosphorylation of p185neu and several other cellular proteins. Thus the neu tyrosine kinase can elicit morphological and biochemical changes resembling, but distinct from, those stimulated by NGF, and heregulin stimulates neu to elicit these effects in PC12 cells.
D C Gamett; R A Cerione
Related Documents :
10728904 - Mitogenesis in glioblastoma multiforme cell lines: a role for ngf and its trka receptors.
9593514 - Inhibitory effects of bulbocapnine on dopamine biosynthesis in pc12 cells.
3533064 - Nerve growth factor enhances the level of the protein kinase c substrate b-50 in pheoch...
12884694 - Pc12 cells as a model for studies of regulated secretion in neuronal and endocrine cells.
9062344 - Cd18/icam-1-dependent oxidative nf-kappab activation leading to nitric oxide production...
10426984 - Photovoltaic technology: the case for thin-film solar cells
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  FEBS letters     Volume:  351     ISSN:  0014-5793     ISO Abbreviation:  FEBS Lett.     Publication Date:  1994 Sep 
Date Detail:
Created Date:  1994-10-13     Completed Date:  1994-10-13     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0155157     Medline TA:  FEBS Lett     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  335-9     Citation Subset:  IM    
Department of Pharmacology, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853-6401.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bucladesine / pharmacology
Cells, Cultured
DNA, Complementary
Enzyme Activation
Glycoproteins / pharmacology
Nerve Growth Factors / pharmacology
PC12 Cells
Proto-Oncogene Proteins / metabolism*
Receptor, Epidermal Growth Factor / metabolism*
Receptor, erbB-2
Tetradecanoylphorbol Acetate / pharmacology
Tyrosine / metabolism
Vanadates / pharmacology
Grant Support
40654//PHS HHS
Reg. No./Substance:
0/DNA, Complementary; 0/Glycoproteins; 0/Ligands; 0/Nerve Growth Factors; 0/Neuregulins; 0/Proto-Oncogene Proteins; 0/Vanadates; 16561-29-8/Tetradecanoylphorbol Acetate; 362-74-3/Bucladesine; 55520-40-6/Tyrosine; EC, Epidermal Growth Factor; EC, erbB-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Opioid ligands with extraordinarily high mu-selectivity: dermorphin tetrapeptides containing thymine...
Next Document:  Molecular cloning and evolutional analysis of a mammalian homologue of the Distal-less 3 (Dlx-3) hom...